DOI: https://doi.org/10.32652/nos.v0i1.133608

Использование современных фармакологических технологий для поиска новых эргогенных средств в спорте: эмпирический анализ и реальный результат

Иван Чекман, Лариса Гунина

Аннотация


Обоснованы целесообразность, эффективность и информативность квантово-фармакологических технологий для поиска новых эргогенных средств на примере L-каротина и мелатонина, детально обсуждены вопросы практического применения таких технологий в практике фармакологии спорта. В результате анализа прогнозирования биологических и фармакологических свойств молекул левокарнитина и мелатонина с использованием современных квантово-фармакологических технологий показана высокая степень совпадения с имеющимися на этот счет в литературе данными, полученными эмпирическим путем при проведении исследований у спортсменов. Наличие новых, не описанных в литературе качеств этих биологически активных субстанций, открывает перспективные направления для применения их в новых сферах фармакологии и медицины спорта. Высокая степень совпадения полученных при квантово-фармакологическом анализе данных с реальными результатами научных исследований обосновывает полную целесообразность таких современных технологий в сфере фармакологии спорта. Это помогает существенно повысить точность прогноза будущих фармакологических свойств новых эргогенных средств, сэкономить материальные ресурсы и время на поиск субстанций, которые могут быть использованы в дальнейшем как средства стимуляции работоспособности и ускорения восстановительных процессов.

Ключевые слова


Спорт; физическая работоспособность; квантовая фармакология; эргогенные средства; анализ структуры молекулы; L-карнитин; мелатонин

Полный текст:

PDF (English) PDF

Литература


Bakishev VI, Kolomoets NM. Melatonin: its role in the system of neurohumoral regulation in man. Klinicheskaia meditsina. 2011;89(2):8-13.

Vinogradov V, Diachenko A. Factors improving the functional abilities of athletes in cyclic endurance sports. Physical activity, health and sport. 2013;3(13):48–59.

Gavrilova EA. Stress-induced immunodefi ciency in athletes. Moscow: Sovetskii sport; 2009. 192 p.

Golovenko MYa. Physical Chemical Pharmacology: monograph. Odesa: Astroprint; 2004. 720 p.

Gunina LM, editor, Vinnichuk YuD, Gorchakova NA, Vysochina NL. Medical-biological support for hockey players. Kyiv: STPC “EXPRESS”; 2013. 319 p.

Gunina LM, Bezuglaya VV, Bagauri OV. Application of the preparation Cardonat to increase tolerance to physical loads. Medicine of Ukraine. 2013;3(169):64–67.

Gunina LM, Chekman ІS, Gorchakova ND, Nebesna TYu, Olіshevskii SV, Golovashchenko RV. Computer prediction of pharmacological activity of L-carnіtine on the basis of molecular structure. Dopovidi NAN Ukrainy. 2011;6:180–187.

Gunina LM, Olishevskii SV, Cherednichenko OO, Golovashchenko RV, Yushkovska OG. Justifi cation of the potential for the use of metabolic preparation «Cardonat» in elite rowers. Sports medicine. 2010;1-2:92–97.

Iordanskaia FA, Yudintseva MS. Health-status monitoring and functional preparedness of elite athletes in the process of training work and competitive activity. Moscow: Sovetskii sport; 2006. 183 p.

Mazur IA, Chekman IS, Belenichev IF. Metabolitotropic preparation. Zaporozhie; 2007. 309 p.

Makarova GA. Sports medicine: textbook. Moscow: Sovetskii sport; 2003. 478 p.

Mashkovskiy MD. Medicines. Moscow: Novaia volna; 2006. 1200 p.

Platonov VN, Oleynik SA, Gunina LM. Doping in sport and the problem of pharmacological support of athletes training. Moscow: Sovetskii sport; 2010. 306 p.

Platonov VN. The system for preparing athletes in Olympic sport. in 2 vols. Кyiv: Olympic literature; 2016. Vol. 2, Ergogenic aids in the system of training and competitive activity of athletes; p.1014–1089.

Popovich IG. 50 years of melatonin: outcomes and perspectives for research. Uspekhi Gerontologii. 2008;21(2):342–344.

Poroikov VV, Filimonov DA, Borodina YuV, Lagunin AA, Kos A. The robustness of biological activity spectra predicting by computer program PASS for non-congeneric sets of chemical compounds. J. Chem. Inform. Comput. Sci. 2000;40(6):1349–1355.

Oleynik SA, Gunina LM, editors. Pharmacology of sport. Kyiv: Olympic literature; 2010. 640 p.

Chekman ІS. Quantum pharmacology: state, perspectives of scientifi c research, implementation of the results into pharmacy practice. Farmatsevtychnyi zhurnal. 2011;2:43–48.

Chekman ІS. Quantum pharmacology. Kyiv: Nauk. Dumka; 2012. 181 p.

Chekman ІS, Kazakova OO, Nebesna TYu. Methods of computer calculations in quantum pharmacology. Pharmacology and drug toxicology. 2008;1:40-46.

Anzali S, Barnickel G, Cezanne B, Krug M, Filimonov D, Poroikov V. Discriminating between Drugs and Nondrugs by Prediction of Activity Spectra for Substances (PASS). Journal of Medicinal Chemistry. 2001;44(15):2432-2437.

Bicer M, Akil M, Avunduk MC. Interactive eff ects of melatonin, exercise and diabetes on liver glycogen levels. Endokrynol. Pol. 2011;62(3):252–256.

Bonnefont-Rousselot D, Collin F. Melatonin: Action as antioxidant and potential applications in human disease and aging. Toxicology. 2010;278(1):55-67.

Brass E. Carnitine and Sports Medicine: Use or Abuse?. Annals of the New York Academy of Sciences. 2004;1033(1):67-78.

Brocks D, Mehvar R. Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial Drugs. Clinical Pharmacokinetics. 2003;42(15):1359-1382.

Curran M, Olson J, Morhart M, Sample D, Chan K. Acetyl-L-carnitine (ALCAR) to enhance nerve regeneration in carpal tunnel syndrome: study protocol for a randomized, placebo-controlled trial. Trials. 2016;17(1).

Dumont M, Lanctôt V, Cadieux-Viau R, Paquet J. Melatonin Production and Light Exposure of Rotating Night Workers. Chronobiology International. 2012;29(2):203-210.

Goel R, Singh D, Lagunin A, Poroikov V. PASS-assisted exploration of new therapeutic potential of natural products. Medicinal Chemistry Research. 2010;20(9):1509-1514.

Holms R, Greenbaum PD, Huang G. The role of L-karnitine in the treatment of myocardial infarction. Result of CEDIM randomize investigation. London; 2010. 254 p.

Karakaş A, Coşkun H, Kaya A, Kücük A, Gündüz B. The eff ects of the intraamygdalar melatonin injections on the anxiety like behavior and the spatial memory performance in male Wistar rats. Behavioural Brain Research. 2011;222(1):141-150.

Karlic H, Lohninger A. Supplementation of l-carnitine in athletes: does it make sense?. Nutrition. 2004;20(7-8):709-715.

La Guardia P, Alberici L, Ravagnani F, Catharino R, Vercesi A. Protection of rat skeletal muscle fi bers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generation. Frontiers in Physiology. 2013;4.

Lagunin A, Filimonov D, Poroikov V. Multi-Targeted Natural Products Evaluation Based on Biological Activity Prediction with PASS. Current Pharmaceutical Design. 2010;16(15):1703-1717.

Lee H, Kim S, Kim D. Eff ects of exercise with or without light exposure on sleep quality and hormone reponses. Journal of Exercise Nutrition and Biochemistry. 2014;18(3):293-299.

Murali P, George S, Ally K, Dipu M. Eff ect of L-carnitine supplementation on growth performance, nutrient utilization, and nitrogen balance of broilers fed with animal fat. Veterinary World. 2015;8(4):482-486.

Ochoa J, Díaz-Castro J, Kajarabille N, García C, Guisado I, De Teresa C et al. Melatonin supplementation ameliorates oxidative stress and infl ammatory signaling induced by strenuous exercise in adult human males. Journal of Pineal Research. 2011;51(4):373-380.

Oliynyk S, Shevchenko V. Ergogenic aids as a means for increasing athlete working capacity in the high altitude environment. Int. J. of Appl. Sports Sci. 2009;21(1):61–73.

Rajasekar P, Balasaraswathi K, Anuradha CV. Eff ects of L-carnitine on RBC membrane composition and function in hyperinsulinemic rats. Ital. J. Biochem. 2007;56(1):53–60.

J. Reiter R, C. Manchester L, Tan D. Neurotoxins: Free Radical Mechanisms and Melatonin Protection. Current Neuropharmacology. 2010;8(3):194-210.

Senn H, Thiel W. QM/MM Methods for Biomolecular Systems. Angewandte Chemie International Edition. 2009;48(7):1198-1229.

Vigoré L, Messina G, Brivio F, Fumagalli L, Rovelli F, Di Fede G, Lissoni P. Psychoneuroendocrine modulation of regulatory T-lymphocyte system: in vivo and in vitro eff ects of the pineal immunomodulating hormone melatonin. In Vivo. 2010;24(5):787–789.

Zhang L, Zhou P, Yang F, Wang Z. Computer-based QSARs for predicting mixture toxicity of benzene and its derivatives. Chemosphere. 2007;67(2):396-401.




Creative Commons License
Эта работа лицензирована Creative Commons Attribution-NonCommercial 4.0 International License.